SFS
ALXN

Sowell Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Sowell Financial Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,026
Closed -$174K – 3166
2021
Q1 		$174K Sell
1,026
-45
-4% -$6.96K 0.01% 1122
2020
Q4 		$167K Buy
1,071
+130
+14% +$16.7K 0.01% 923
2020
Q3 		$108K Buy
941
+10
+1% +$1.08K 0.01% 948
2020
Q2 		$104K Buy
931
+13
+1% +$1.38K 0.01% 953
2020
Q1 		$82K Buy
918
+304
+50% +$29.8K 0.01% 910
2019
Q4 		$66K Buy
614
+64
+12% +$6.84K 0.01% 1056
2019
Q3 		$54K Buy
+550
New +$62K ﹤0.01% 976

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return